Concepedia
Author
Laurence Bessac
Also Known As
L Bessac, Laurence Bessac
14
Publications
620
Citations
5
H-Index
0
Concepts
All Affiliations
×
All Concepts
604
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Gregory G. Schwartz, Laurence Bessac, Lisa G. Berdan, +20
American Heart Journal
2014
409
Reductions in Atherogenic Lipids and Major Cardiovascular Events
Kausik K. Ray, Henry N. Ginsberg, Michael H. Davidson, +5
Circulation
2016
128
Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
Antonio J. Vallejo‐Vaz, Henry N. Ginsberg, Michael H. Davidson, +7
Journal of the American Heart Association
2018
27
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control
Antonio J. Vallejo‐Vaz, Kausik K. Ray, Henry N. Ginsberg, +7
Atherosclerosis
2019
26
Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials
Harold Bays, Lawrence A. Leiter, Helen M. Colhoun, +4
2017
Page 1